The PE Ratio as of June 2026 (TTM) for Santen Pharmaceutical Co., Ltd. (SNPHY) is 16.79

According to Santen Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 16.79. This represents a change of 0.82% compared to the average of 16.65 of the last 4 quarters.

Santen Pharmaceutical Co., Ltd. (SNPHY) Historical PE Ratio (quarterly & annually)

How has SNPHY PE Ratio performed in the past?

The mean historical PE Ratio of Santen Pharmaceutical Co., Ltd. over the last ten years is 20.59. The current 16.79 PE Ratio has changed 8.06% with respect to the historical average. Over the past ten years (40 quarters), SNPHY's PE Ratio was at its highest in in the March 2024 quarter at 4.30K. The PE Ratio was at its lowest in in the March 2021 quarter at -13.02.

Santen Pharmaceutical Co., Ltd. (SNPHY) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Santen Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Santen Pharmaceutical Co., Ltd. (SNPHY) Average PE Ratio

How has SNPHY PE Ratio performed in the past?

The current PE Ratio of Santen Pharmaceutical Co., Ltd. (SNPHY) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Santen Pharmaceutical Co., Ltd. (SNPHY) PE Ratio vs. Peers

How is SNPHY’s PE Ratio compared to its peers?

Santen Pharmaceutical Co., Ltd.’s PE Ratio is greater than MediPal Holdings Corporation (12.38), less than Virbac S.A. (18.92), greater than The United Laboratories International Holdings Limited (6.72), greater than MediPal Holdings Corporation (12.38), greater than Haw Par Corporation Limited (13.52), greater than Shandong Weigao Group Medical Polymer Company Limited (8.05), less than Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (34.95), greater than Haw Par Corporation Limited (13.52), greater than Sundrug Co.,Ltd. (13.94), greater than Bavarian Nordic A/S (11.85),

Build a custom stock screener for Santen Pharmaceutical Co., Ltd. (SNPHY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Santen Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Santen Pharmaceutical Co., Ltd. (SNPHY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Santen Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.